Burden of Hyperglycemia in Patients Receiving Corticosteroids for Severe COVID-19

Although corticosteroid therapy is the standard of care for all patients hospitalized with severe coronavirus disease 2019 (COVID-19), the studies demonstrating the mortality–benefit ratio of corticosteroids were limited to fully evaluate their adverse effects. To determine the severity of corticost...

Descripción completa

Detalles Bibliográficos
Autores principales: Fetters, Kirk B., Judge, Stephen P., Daar, Eric S., Hatlen, Timothy J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359482/
https://www.ncbi.nlm.nih.gov/pubmed/35966031
http://dx.doi.org/10.1016/j.mayocpiqo.2022.07.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359482/
https://www.ncbi.nlm.nih.gov/pubmed/35966031
http://dx.doi.org/10.1016/j.mayocpiqo.2022.07.004

Ejemplares similares